\documentclass[9pt,twocolumn,twoside]{gsajnl}
\include{hyperref}
\articletype{inv} % article type
% {inv} Investigation 
% {gs} Genomic Selection
% {goi} Genetics of Immunity 
% {gos} Genetics of Sex 
% {mp} Multiparental Populations

\title{Microarray-based detection of genomic signatures related with the tumor recurrence in Glioblastoma patients}

\author[$\ast$,1]{Álvaro Abella-Bascarán}
\author[$\ast$]{Eloi Casals-Puig}
\author[$\ast$]{Samuel Miravet-Verde}

\affil[$\ast$]{Pompeu Fabra University, Barcelona (Spain)}

\keywords{Microarray; tumour recurrence; glioblastoma.}

\runningtitle{GENETICS | INVESTIGATION} % For use in the footer 

\correspondingauthor{Corresponding Author}

\begin{abstract}

Glioblastoma tumors, in addition to be the most frequent and aggressive type of brain tumor in humans, are notorious for their resistance to therapy. The aim of this work was to identify which molecular profiles are related with resistance to treatment, by means of the analysis of microarray data from 80 tumor samples (proceeding from the work of \citep{Murat2008}). The analysis led to 
% TODO one line for results in the abstract
\end{abstract}

\begin{document}

In total 66 genes unique underexpressed in recurrent patients, and 116 overexpressed.

\begin{table*}[htbp]
\centering
\caption{\bf Underexpressed Genes}
\begin{tableminipage}{\textwidth}
\begin{tabularx}{\textwidth}{m{3cm}m{3.5cm}m{1.2cm}m{9.2cm}}
\hline
Biological Processes & GOBPID terms & nº genes & Genes included\footnote{Genes can overlap between GO terms.} \\
\hline

Cell surface receptors pathways & GO:0007166 & 29 & ACTR2, LILRB1, CYLD, ATP6V0E2, EFNB2, CCNY, PEG10, NPB, ADGRD1, TMEM145, IFNGR1, ITGB8, KRAS, NCK1, PDPK1, PRKACB, BIRC6, CEACAM1, RGS18, BMP2, TIAM1, CA2, CPEB4, DYRK2, CBL, KAT2B, ACVR1B, USP34, P2RY14\\

Negative regulation of cell cycle, proliferation \& apoptosis& GO:0051726, GO:0008285, GO:0097190 & 23 & TMOD3, FABP7, LILRB1,TOM1L1, CD33, PRPF40A, DYRK2, NCK1, PRKACB, CYLD, EFNB2, PDPK1, NACC2, ARL6IP5, BIRC6, RBL2, CCNY, TIAM1, SF1, KAT2B, CTBP1, ACVR1B , BMP2\\

Immune response \& Cell Adhesion & GO:0045088, GO:0051249, GO:0002684, GO:0006955, GO:1903037, GO:0034110  & 16 & PDPK1, CYLD, SUSD4, TLR5, CA2, ACTR2, SPPL2A, LST1, HAMP, LILRB1, PRKACB, IFNGR1,LILRB1, ACVR1B, SASH3, NCK\\

Regulation of hydrolase activity & GO:0051336 & 14 & ARL6IP5, CST3, ITSN2, ASAP1, PDPK1, SERPINB6, PRKACB, BIRC6, ARHGAP9, RGS18, BMP2, WNK1, TIAM1, DENND1C\\ 

RNA processing & GO:0006396 & 9 & SRRM1, PAPD4, DHX36, HNRNPA2B1, PRPF40A, RP9, SF1, SLBP, SCAF11\\

Axon Guidance & GO:0007411 & 7 & ACTR2, EFNB2, KIF5C, KRAS, NCK1, TIAM1, ZIC2\\

Negative regulation of protein transport & GO:0051224 & 5 & LYPLA1, LILRB1, CYLD, RHBDF2, DYRK2\\

Activation of protein kinase activity & GO:0032147 & 5 & TOM1L1, KRAS, PDPK1, PRKACB, BMP2\\
\hline
\end{tabularx}
  \label{tab:shape-functions}
\end{tableminipage}
\end{table*}

\pagebreak
 

\begin{table*}[htbp]
\centering
\caption{\bf Overexpressed Genes}
\begin{tableminipage}{\textwidth}
\begin{tabularx}{\textwidth}{m{3cm}m{3.5cm}m{1.2cm}m{9.2cm}}
\hline
Biological Processes & GOBPID terms & nº genes & Genes included\footnote{Genes can overlap between GO terms.} \\
\hline

Metabolic Processes & GO:1903050  GO:0042180  GO:0045862  GO:0034655  GO:0005996  GO:0006066  GO:0044265  GO:0043085, GO:0043170 & 82 &  RPP30, ASB1, RTCB, ZNF397, NRBP1, U2AF1, PIGC,  CYR61,  FUCA1, CFH, FBXW7, PCMTD1, PSMD4, CCL5, MAN1B1, PRMT1, MYDGF, COL12A1, SEC31A, PSMC1, DRG1, RPL27A, ATG10, ZNF554, PSMD3, APOL2, TRAPPC2, GSTP1, CYR61,  PMVK, WDR46, FUCA1, CCNB1IP1, BAX, DIS3, STX12, ZNF426, APOL3, SLC35D2, PTGER3, SLC35B4, CTNNB1, RETSAT, RPS9, POLR3GL, RGS4,  FBXW7, SAMD4B, NPY1R, EIF6, USP7, USP7 , INPPL1, TRIP6, PPAP2A,  SEC31A, LIG4, POLR3C, ZCCHC11, ATF5, MFAP4, TOB2, OGT,  PDE10A,TIMM17A, OSR2, ZBTB26, CCS, ZNF791, PIN1, NUDT4, CTSD, DPH5, COPS6, CCL8, RPE65, SNF8, ZNF496,  MAN1B1, OBFC1, APOBEC3F, RPA2\\

Cell structure organization & GO:0043062, GO:0044419, GO:0051234, GO:0051640 & 54 & APOL2, NUDT4, CALU, SLC39A7, COPA, CCL8,COL12A1, USP7, EIF6, TMED9, ECM2, BAX, CYR61, ABI3BP, ATG10, CCS, APOL3, SEC31A, ANTXR2, TRAPPC2, CCL5, TRIP6, HNMT, SLC35B4, INPPL1, TIMM17A, TMEM63A, NRBP1, COPS6, PSMC1, SNF8, FBXW7, HOMER3, MCOLN2, STX12, PTGER3, SYTL5, PSMD3, SNCAIP, PSMD4, RPL27A, CTNNB1, CTSD, RPS9, PEX16, RIMS4, WDR46, U2AF1, SLC26A7, ARF5, LIG4, SLC35D2, MFAP4, APOBEC3F\\

Transport and Homeostasis & GO:0006887, GO:0016482, GO:0006816, GO:0072511, GO:0060249,  GO:0051650, GO:0044765 & 43 & SLC35B4, TMEM63A, U2AF1, HOMER3, SLC39A7, MCOLN2, WDR46, OBFC1,  COPA, SLC26A7, CCS  , TMED9, EIF6, COPA, NRBP1, TIMM17A, APOL2, CALU, SYTL5, NUDT4, SLC35D2, SNCAIP, SNF8,SNF8, SEC31A, RPL27A, BAX, SYTL5  TIMM17A, STX12, RPS9, CTNNB1, CCL5, APOL3, HNMT,  CTNNB1, CCL8, TRAPPC2, TRIP6, RPA2, RPE65, RIMS4, PEX16, PTGER3\\

Protein Modification & GO:1903322, GO:0032259, GO:0031400, GO:0006605, GO:0032446, GO:0051338 & 32 & ATG10, SNF8, RPS9, BAX, TIMM17A, PRMT1, PIN1, OGT, PSMD4, OGT , FBXW7, PSMC1, HNMT, RPL27A, DPH5, CYR61, GSTP1,  PCMTD1, PSMD3,  CTNNB1, ASB1, PEX16,  SEC31A,PIN1, RGS4, MYDGF, TRIP6, CTNNB1, HOMER3, CCL5 , WDR46, CCNB1IP1\\

Immune Response \& Inflamation & GO:0002478, GO:0019882, GO:0016032, GO:0001817, GO:0006954  & 28 & CFH, PSMD3, GSTP1, FBXW7, RPS9,  COPS6, PSMC1, POLR3GL,  APOL2, ASB1, SNF8, APOBEC3F, PSMD4,CTSD, BAX, ZCCHC11, RPL27A,  POLR3C, LIG4,  CTSD, PTGER3, APOL3  , USP7, PIN1, SEC31A, CTNNB1, CCL8, CCL5\\

Negative regulation of apoptosis \& cell death & GO:0030111, GO:0060548, GO:0043066  & 15 & MYDGF, CYR61,  CTNNB1,WIF1, CCL5, PSMC1,  ATF5, BAX, PSMD3, CTNNB1, GSTP1, PSMD4, LIG4, ATF5, CCL5\\

\hline
\end{tabularx}
  \label{tab:shape-functions}
\end{tableminipage}
\end{table*}


\end{document}

\end{document}
